Elsevier

Tuberculosis

Volume 92, Issue 6, November 2012, Pages 513-520
Tuberculosis

Immunological aspects
Diagnostic performance of multiplex cytokine and chemokine assay for tuberculosis

https://doi.org/10.1016/j.tube.2012.06.005Get rights and content

Summary

Simultaneous detection of multiple biomarkers might lead to improved diagnostic performance for Mycobacterium tuberculosis infection. In this study, we screened soluble biomarkers that had significant differences in patients with active tuberculosis and healthy controls and evaluated the diagnostic performance of the multiplex cytokine/chemokine assay. Overall, 178 patients with active pulmonary tuberculosis, 156 healthy individuals and 35 patients with bacterial pneumonia or lung cancer were evaluated. Among the 16 soluble biomarkers screened by the microbead-based multiplex assay, five cytokines/chemokines including IFN-γ, IP-10, MIG, TNF-α and IL-2 that showed most significant differences between active pulmonary tuberculosis patients and healthy controls were selected for further analysis. When analyzed individually, both IP-10 and MIG had sensitivity and specificity comparable to IFN-γ in detection of active TB. Combined detection of IFN-γ, IP-10 and MIG had significantly improved sensitivity and specificity as compared with individual cytokine and chemokine detection. The responsive levels of IFN-γ, IP-10, MIG, TNF-α and IL-2 were significantly lower in re-treatment pulmonary tuberculosis patients than in new tuberculosis patients. It is concluded that combined IFN-γ, IP-10, MIG multiplex detection had better diagnostic performance for tuberculosis than the individual cytokine/chemokine assays. The re-treatment pulmonary tuberculosis patients had poor responses to ESAT-6/CFP-10 peptides stimulation.

Introduction

Despite availability of inexpensive and relatively effective therapy, tuberculosis (TB) continues to be a major global health problem.1, 2 It is estimated that 9.27 million new cases of TB occurred in 2007 and 4.1 million were smear-positive.3 Due to low efficacy of BCG vaccine, control of this disease largely depends on early diagnosis and treatment.

The current TB diagnosis mainly depends on detection of mycobacteria by acid-fast staining and/or fluorescent microscopy, as well as by bacterial culture that can also be used for subsequent drug susceptibility tests.4 Sputum smear microscopy has low sensitivity and Mycobacterium tuberculosis culture takes at least two weeks, normally 4–8 weeks, which often lead to delays in diagnosis and treatment.5 Fast nucleic acid-based assays have been developed, with variable sensitivity for direct identification of M. tuberculosis from clinical samples.6

IFN-γ release assays (IGRAs) have been introduced into clinical practice for the diagnosis of M. tuberculosis infection, and are used together with other tests to assist diagnosis of active TB in many countries.7, 8, 9, 10, 11 The current commercially available IGRA kits, such as T-SPOT.TB and QuantiFERON-TB Gold in-tube, depend on detection of a single cytokine, IFN-γ, which are influenced by many parameters. Due to high rate of latent TB infection (LTBI) in high-burden countries, current IGRAs have relatively low performance in diagnosis of active TB.12 A number of other cytokines produced from specifically stimulated cells were also explored for the diagnosis of TB, such as IP-10, IL-2 and TNF-α, and some were found to be promising biomarkers.13, 14, 15

Microarray analysis of whole blood identified 393 transcripts that can discriminate active TB from latent infection.16 Flow cytometric detection of M. tuberculosis antigen-specific TNF-α,13 and/or IFN-γ/IL-2 responses has been found to be promising in diagnosis of active TB.17 It is reported that proportions of multifunctional CD4+ T cells that express IFN-γ, IL-2 and TNF-α were significantly different in individuals with active TB and latent TB infection, and were associated with responses to anti-TB chemotherapy.18 Therefore, multiple biomarker detection might have the potential to improve the accuracy and sensitivity of TB diagnosis.

Multiplex microbead-based assay allows for detection of many different soluble proteins simultaneously from the same sample.19 To develop new microbead-based multiplex assay for TB diagnosis, we initially examined 16 soluble proteins, including cytokines, chemokines and some other molecules that involve in immune and inflammatory responses to mycobacterial antigen stimulation, and compared their expression levels in patients with active TB and healthy controls. Five cytokines/chemokines including IFN-γ, IP-10, MIG, TNF-α and IL-2 that showed most significant differences between active TB patients and healthy controls were selected for the multiplex assays and evaluated for diagnostic performance in high TB burden settings.

Section snippets

Study subjects

In this study, 178 patients with active pulmonary TB, 156 healthy control individuals and 35 patients with bacterial pneumonia or lung cancer were recruited. Patients with active pulmonary TB were recruited from the TB Clinical Center of the Institute of Tuberculosis, 309 Hospital, Beijing, China (Table 1). Diagnosis of pulmonary TB was based on positive sputum smears and/or culture results and chest radiography. For patients with negative bacterial culture results, diagnosis was established by

Simultaneous detection of multiple cytokines and chemokines by microbead-based assay

In our preliminary studies, 16 proteins including IL-1α, IL-2, IL-4, IL-6, IL-10, IL-17A, IFN-γ, TNF-α, TGF-β1, IP-10 (CXCL10), MIG (CXCL9), MCP-1 (CCL2), MIP-1β (CCL4), EGF, sCD40L, VEGF-A were measured by using culture supernatant of PBMCs from patients with active pulmonary TB and healthy control individuals after stimulation with ESAT-6 and CFP-10 peptides pool. Five cytokines, IFN-γ, IP-10, MIG, TNF-α and IL-2, that showed most significant differences between the active TB patient and

Discussion

Due to low sensitivity of mycobacterial smear/culture methods for diagnosis of TB, alternative diagnostic methods are explored extensively, especially for smear/culture-negative TB patients.4, 5 IGRA is considered a breakthrough in TB immunodiagnostic and has high specificity and sensitivity for detection of M. tuberculosis infection, however, it was reported that it has relatively low sensitivity in detection of active TB.12, 22 We hypothesize that multiplex biomarker detection might improve

Ethical approval

The study was approved by the Ethics Committee of the Beijing 309 Hospital and informed consent was obtained from all participants.

Funding

The study was supported by grants from National Natural Science Foundation of China (81071318, 81071319 and 81061120518), a grant from Beijing Natural Science Foundation (7092100) and a grant for infectious diseases from Ministry of Health and Ministry of Science and Technology, China to XC (2008ZX10003-012).

Conflict of interest

None.

References (42)

  • L. Li et al.

    CD4+ CD25+ Treg cells inhibit human memory gammadelta T cells to produce IFN-gamma in response to M tuberculosis antigen ESAT-6

    Blood

    (2008)
  • X. Wang et al.

    Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis

    J Infect

    (2011)
  • X. Wang et al.

    Association of mycobacterial antigen-specific CD4(+) memory T cell subsets with outcome of pulmonary tuberculosis

    J Infect

    (2010)
  • M.S. Jassal et al.

    Epidemiology and challenges to the elimination of global tuberculosis

    Clin Infect Dis

    (2010)
  • J.A. Caminero

    Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding

    Int J Tuberc Lung Dis

    (2010)
  • Global tuberculosis control: epidemiology, strategy, financing

    (2009)
  • S.E. Dorman

    New diagnostic tests for tuberculosis: bench, bedside, and beyond

    Clin Infect Dis

    (2010)
  • M.L. Wilson

    Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance

    Clin Infect Dis

    (2011)
  • M. Pai et al.

    Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

    Ann Intern Med

    (2008)
  • C. Jafari et al.

    Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study

    Am J Respir Crit Care Med

    (2009)
  • A. Lalvani et al.

    100 year update on diagnosis of tuberculosis infection

    Br Med Bull

    (2010)
  • Cited by (34)

    • A systematic review of potential screening biomarkers for active TB disease

      2021, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
      Citation Excerpt :

      7158 titles were excluded at the title/abstract level, leaving 481 articles for full-text review. We included 79 studies for full data extraction and review [16–94]. The full characteristics of the 79 included studies are described in Online Supplement 3.

    • Engineered Mycobacterium tuberculosis antigen assembly into core-shell nanobeads for diagnosis of tuberculosis

      2021, Nanomedicine: Nanotechnology, Biology, and Medicine
      Citation Excerpt :

      Another study, which determined 12 cytokines in the QFT-GIT stimulated samples, identified a biosignature of 5 cytokines combining stimulated and non-stimulated samples resulting in a sensitivity and specificity of 64.2 & 82.7% for TB diagnosis.38 After the stimulation of PMBC (peripheral blood mononuclear cells) with ESAT6 and CFP10 peptides, the sensitivity and specificity of IFNγ, IP10 and CXCL9 (MIG), for TB diagnosis, showed combined values above 80%.39 The combination of these 3 cytokines showed better specificity than any of the individual cytokines.39

    • Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting

      2019, Tuberculosis
      Citation Excerpt :

      Therefore, an immune-based blood test that can make this distinction would be a major advance. The dynamic nature of the interaction between MTB and the host immune system suggests that a combination of biomarkers may prove to be more sensitive and specific than a single biomarker alone [19]. Many TB studies have focussed on biomarker sensitivity, often overlooking the importance of specificity [20,21].

    • Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype

      2017, Tuberculosis
      Citation Excerpt :

      Therefore, CCL2 levels from either the TBAg or the Unstim condition could be used as the biomarker. Previous studies suggested variable performance of multiple cytokines and chemokines for ATB and LTBI diagnosis [26,28,30]. Such combinations have the potential to improve diagnosis of ATB and LTBI.

    View all citing articles on Scopus
    c

    Both authors contributed equally to the work.

    View full text